Latest Data and Live Broadcast Show Promise of Vascular Dynamics’ MobiusHD Device IRVINE, Calif.–(BUSINESS WIRE)–Vascular Dynamics, Inc. (VDI), a privately held medical device company focused on developing game-changing endovascular device-based solutions for patients suffering from heart failure, announced that the endovascular baroreflex amplification (EVBA) procedure using its MobiusHD device to […]
Author: Ken Dropiewski
Soleo Health Selected by Novartis as Limited Drug Distribution Partner for Administration of LEQVIO®
Company to Distribute Recent FDA-Approved Treatment for Reducing Bad Cholesterol FRISCO, Texas–(BUSINESS WIRE)–Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it has been selected as a limited distribution partner for cardiovascular drug LEQVIO®, manufactured by Novartis, a leading global medicines company. LEQVIO (inclisiran) injection is […]
Viz.ai Partners with Hyperfine to Enable New MR Imaging and Workflow Paradigm
SAN FRANCISCO–(BUSINESS WIRE)–Viz.ai, the leading AI-powered disease detection and intelligent care coordination platform, announced today it is partnering with Hyperfine, Inc. (Nasdaq: HYPR), creator of the first FDA-cleared point-of-care magnetic resonance imaging (MRI) device, Swoop®. Together, they will bring MRI to the patient’s bedside and deliver valuable insights to the clinician’s fingertips for timely […]
WERFEN ANNOUNCES WORLDWIDE COMMERCIAL RELEASE OF GEMWEB® LIVE REAL-TIME ONSCREEN VIEWER
— Designed to Enable Time-Critical Clinical Decisions in Cardiac Surgery — BEDFORD, Mass., July 25, 2022 /PRNewswire/ — Werfen today announced the worldwide commercial release of GEMweb Live, a real-time onscreen viewer of diagnostic test results for cardiac surgical procedures. Comprehensive, rapid test results are viewed in real-time on one screen, designed […]
Philips’ performance impacted by headwinds; order book strength and improving component supplies expected to deliver growth and profitability improvement from second half of 2022 onwards
Highlights Group sales amounted to EUR 4.2 billion, with a 7% comparable sales decline mainly caused by continued supply shortages and prolonged lockdowns in China, on the back of 9% comparable sales growth in Q2 2021 Order book remains strong; comparable order intake increased 1% and includes a 5 percentage-points […]
Route 92 Medical’s Monopoint® Operating Platform Shows 82% First Pass Effect in Independent Study
SAN MATEO, Calif., July 25, 2022 (GLOBE NEWSWIRE) — Route 92 Medical, Inc., a private medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced the publication of an investigator-initiated, multicenter SLIC study of its proprietary Monopoint® operating platform showing 82% first pass efficacy. Results from 33 […]
Vizient Announces Strategic Partnership with Mpirik to Improve Care, Health Equity in Cardiology with Help From AI
IRVING, Texas–(BUSINESS WIRE)–Vizient, Inc., the nations’ largest member-driven health care performance improvement company, today announced a strategic partnership agreement with Mpirik, a cloud-based care pathway software company focused on cardiac care, that will enable physicians to make more informed decisions on patient care while helping to reduce undertreatment. The strategic partnership […]
NewAmsterdam Pharma Holding B.V. and Frazier Lifesciences Acquisition Corporation Announce Merger Agreement to Create Publicly Listed Company Focused on Transformative Oral Therapies for Major Cardiometabolic Diseases
– Leading institutional investors commit approximately $235 million through an oversubscribed and upsized private investment in public equity (“PIPE”) led by Frazier Healthcare Partners and Bain Capital Life Sciences – – Total proceeds expected to bring pro forma cash balance to at least $470 million; expected to extend cash runway of NewAmsterdam through 2026, funding all expected pre-approval milestones for […]
Heart Health Innovator Cleerly Closes Series C Funding Round with $192 Million High-profile investors led by T. Rowe Price and Fidelity back a new standard of care for cardiovascular disease
This press release was updated on July 28, 2022 to reflect that Cleerly secured additional Series C funding, raising its round total from $192 million to $223 million. Updated July 28, 2022: New York – July 25, 2022 — Cleerly, the company creating a new standard of care for heart disease, announced […]
IRRAS AB publishes Interim Report for the period January to June 2022
STOCKHOLM, July 22, 2022 /PRNewswire/ — Continued progress during Q2 2022 ” The second quarter of 2022 provided the latest data point to confirm IRRAS’ progress toward becoming a leader in neurocritical care. Q2 represented the 8th consecutive quarter of revenue growth for our company, and our revenue of MSEK 9.7 (5.1) […]



